Tuesday, February 3, 2026, shapes up as one of the most consequential days of the fourth-quarter earnings season, with a diverse slate of reports from consumer staples giant PepsiCo, battered fast-casual chain Chipotle, AI chip challenger AMD, payments leader PayPal, and pharmaceutical heavyweight Merck. Together, these five companies will provide a comprehensive read on the American consumer, the AI investment cycle, and the post-pandemic healthcare landscape.
PepsiCo: Testing Consumer Staples Resilience
PepsiCo reports before the market opens at 8:15 a.m. Eastern, with analysts expecting a 10 percent increase in earnings per share driven by strong international demand. The snack and beverage conglomerate has benefited from successful pricing actions over the past two years, though volume growth has shown signs of strain as consumers trade down to value alternatives.
UBS analyst Peter Grom has called PepsiCo "one of the few large-cap Staples names with a strong case for multiple expansion," citing the company's balanced portfolio and emerging market growth potential. The earnings report will be closely watched for commentary on consumer behavior, particularly whether the "trading down" trend that benefited dollar stores throughout 2025 has begun affecting premium packaged goods brands.
With the Conference Board's Consumer Confidence Index at its lowest level since 2014, PepsiCo's results will reveal whether consumer staples remain a defensive haven or whether even essential spending is coming under pressure.
Chipotle: A Comeback Story or Continued Struggle?
Chipotle Mexican Grill reports after the closing bell, with a conference call scheduled for 4:30 p.m. Eastern. The fast-casual chain enters the report under pressure, having lost more than a third of its market value over the past year after cutting its sales outlook last quarter.
LSEG consensus expects a slight decline in earnings per share, reflecting the challenging environment for restaurants caught between rising food costs—particularly beef and avocados—and consumers' growing price sensitivity. The tariff-driven increase in food costs has squeezed margins across the restaurant industry, with chains struggling to pass through price increases without losing traffic.
Telsey Advisory Group analyst Sarang Vora sees 2026 as a potential "comeback story" for Chipotle, contingent on the company demonstrating improved traffic trends and progress on its digital initiatives. The report will reveal whether Chipotle has found its footing or whether the challenges that plagued the chain in late 2025 have persisted.
AMD: The AI Chip Challenger's Moment
Advanced Micro Devices reports after the close, with analysts expecting approximately 20 percent earnings growth and revenue of $9.69 billion, representing 26.6 percent year-over-year growth. The report comes at a pivotal moment for AMD, which is attempting to establish itself as a credible alternative to Nvidia in the AI accelerator market.
AMD's data center segment has been the growth engine, powered by the ramp of its Instinct MI350 Series GPUs and continued server CPU share gains against Intel. The company announced a multiyear agreement with OpenAI to deploy 6 gigawatts of Instinct GPUs, potentially generating over $100 billion in revenue over the next several years.
However, AMD's stock trades at a forward P/E ratio of 124.63, embedding significant growth expectations. The report will need to demonstrate that the company can maintain its momentum against an increasingly competitive Nvidia, which recently hit a $275 billion backlog for its AI chips.
PayPal: The Fintech 'Sleeping Giant' Update
PayPal Holdings reports after the close, providing an update on CEO Alex Chriss's turnaround efforts at the payments company. After years of underperformance, PayPal has been repositioning itself for the new era of digital commerce, emphasizing checkout conversion, merchant services, and its Venmo ecosystem.
Analysts will be watching for signs that PayPal is gaining traction with its new product initiatives, including Fastlane checkout and advanced fraud detection tools. The company faces intensifying competition from Apple Pay, Google Pay, and buy-now-pay-later services, requiring continued innovation to maintain relevance.
Merck: Big Pharma's Post-COVID Test
Merck & Co. rounds out Tuesday's pharmaceutical earnings, following Pfizer's morning report. The pharmaceutical giant is navigating the transition from its COVID-19 treatments to its core oncology and vaccine franchises, led by blockbuster cancer drug Keytruda.
Investors will be focused on Keytruda's growth trajectory as the drug approaches its patent expiration in the coming years. Merck has been aggressively pursuing business development to fill the expected revenue gap, and commentary on pipeline progress and M&A appetite will be closely scrutinized.
The Bigger Picture
Tuesday's earnings slate arrives during the most crowded week of the Q4 2025 reporting season, with more than 110 S&P 500 companies releasing results. So far, 77 percent of companies have beaten earnings estimates, and aggregate earnings growth has reached 11.9 percent year-over-year—among the strongest quarters since the pandemic.
Yet the contrast between corporate earnings strength and consumer confidence weakness presents a puzzle for investors. If companies continue delivering strong results while confidence indicators signal recession risk, either the surveys are overstating pessimism or corporate earnings are about to face a reckoning.
Tuesday's reports won't resolve this tension definitively, but they will provide crucial data points on whether the American consumer—the engine of two-thirds of U.S. economic activity—is holding up better than sentiment suggests or whether the storm clouds visible in confidence data are beginning to affect the top and bottom lines of America's leading companies.
